Recombinant virus vaccines : methods and protocols /

Saved in:
Bibliographic Details
Imprint:New York : Humana Press : Springer, [2017]
©2017
Description:1 online resource (x, 273 pages) : illustrations (chiefly color)
Language:English
Series:Methods in molecular biology ; 1581
Methods in molecular biology (Clifton, N.J.) ; v. 1581.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11272997
Hidden Bibliographic Details
Other authors / contributors:Ferran, Maureen C., editor.
Skuse, Gary R., editor.
ISBN:9781493968695
1493968696
9781493968671
149396867X
Digital file characteristics:text file PDF
Notes:Includes bibliographical references and index.
Online resource; title from PDF title page (SpringerProtocols, viewed April 5, 2017).
Summary:This volume provides readers with methods and protocols for understanding the development of recombinant viruses and their use as vaccines platforms. Recombinant Virus Vaccines: Methods and Protocols details the use of recombinant vaccines that are employed to either produce immunogens in vitro or elicit antibody production in vivo. The chapters in this book are divided into four parts: Part I explores double-stranded DNA viruses; Part II discusses negative sense single-stranded RNA viruses; Part III talks about positive sense single-stranded RNA viruses; and Part IV describes bacteriophages. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Thorough and cutting-edge, Recombinant Virus Vaccines: Methods and Protocols is a valuable resource for scientists and clinicians who are interested in learning about and adopting methods for use in basic and biomedical research directed toward generating and developing recombinant viral vaccines.
Other form:Print version: Recombinant virus vaccines . New York : Springer, ©2017 9781493968671
Standard no.:10.1007/978-1-4939-6869-5

MARC

LEADER 00000cam a2200000Ii 4500
001 11272997
006 m o d
007 cr cn|||||||||
008 170405s2017 nyua ob 001 0 eng d
005 20240705145126.8
015 |a GBB8L6891  |2 bnb 
016 7 |a 101708868  |2 DNLM 
016 7 |a 019127361  |2 Uk 
019 |a 985693593  |a 985833563  |a 986096613  |a 986481657  |a 986611728  |a 986876117  |a 992502718  |a 1005832569  |a 1008959932  |a 1026947605  |a 1048164466 
020 |a 9781493968695  |q (electronic bk.) 
020 |a 1493968696  |q (electronic bk.) 
020 |z 9781493968671  |q (print) 
020 |z 149396867X 
024 7 |a 10.1007/978-1-4939-6869-5  |2 doi 
035 |a (OCoLC)981473901  |z (OCoLC)985693593  |z (OCoLC)985833563  |z (OCoLC)986096613  |z (OCoLC)986481657  |z (OCoLC)986611728  |z (OCoLC)986876117  |z (OCoLC)992502718  |z (OCoLC)1005832569  |z (OCoLC)1008959932  |z (OCoLC)1026947605  |z (OCoLC)1048164466 
035 9 |a (OCLCCM-CC)981473901 
037 |a com.springer.onix.9781493968695  |b Springer Nature 
040 |a RML  |b eng  |e pn  |c RML  |d RML  |d SCB  |d OCLCO  |d GW5XE  |d OCLCF  |d YDX  |d UAB  |d OCLCO  |d OCLCQ  |d AZU  |d OTZ  |d VT2  |d TFH  |d OCLCO  |d MERER  |d OCLCO  |d OCLCA  |d BUF  |d OCLCO  |d CAUOI  |d OCLCO  |d OCLCQ  |d U3W  |d OCLCO  |d OCLCQ  |d UKMGB  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCA 
049 |a MAIN 
050 4 |a QR189.5.V5 
060 4 |a WC 25 
245 0 0 |a Recombinant virus vaccines :  |b methods and protocols /  |c edited by Maureen C. Ferran and Gary R. Skuse. 
264 1 |a New York :  |b Humana Press :  |b Springer,  |c [2017] 
264 4 |c ©2017 
300 |a 1 online resource (x, 273 pages) :  |b illustrations (chiefly color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Methods in molecular biology ;  |v 1581 
588 0 |a Online resource; title from PDF title page (SpringerProtocols, viewed April 5, 2017). 
504 |a Includes bibliographical references and index. 
505 0 0 |t Development of novel vaccines against infectious diseases based on chimpanzee adenoviral vector /  |r Chao Zhang, Yudan Chi, and Dongming Zhou --  |t Development of recombinant canarypox viruses expressing immunogens /  |r Débora Garanzini, María Paula Del Médico-Zajac, and Gabriela Calamante --  |t Fowl adenovirus-based vaccine platform /  |r Juan C. Corredor, Yanlong Pei, and Éva Nagy --  |t Development of recombinant HSV-based vaccine vectors /  |r Richard Voellmy, David C. Bloom, Nuria Vilaboa, and Joyce Feller --  |t Generating recombinant pseudorabies virus for use as a vaccine platform /  |r Feifei Tan, Xiangdong Li, and Kegong Tian --  |t Generation and production of modified vaccinia virus ankara (MVA) as a vaccine vector /  |r Vincent Pavot, Sarah Sebastian, Alison V. Turner, Jake Matthews, and Sarah C. Gilbert --  |t Poxvirus safety analysis in the pregnant mouse model, vaccinia, and raccoonpox viruses /  |r Rachel L. Roper --  |t Development of recombinant arenavirus-based vaccines /  |r Luis Martínez-Sobrido and Juan Carlos de la Torre --  |t Development of recombinant measles virus-based vaccines /  |r Michael D. Mühlebach and Stefan Hutzler --  |t Recombinant tri-segmented pichinde virus as a novel live viral vaccine platform /  |r Rekha Dhanwani, Hinh Ly, and Yuying Liang --  |t Human rhinovirus-A1 as an expression vector /  |r Khamis Tomusange, Danushka Wijesundara, Eric James Gowans, and Branka Grubor-Bauk --  |t Generating recombinant vesicular stomatitis viruses for use as vaccine platforms /  |r John B. Ruedas and John H. Connor --  |t Alphavirus-based vaccines /  |r Kenneth Lundstrom --  |t Display of HIV-1 envelope protein on lambda phage scaffold as a vaccine platform /  |r Jonelle L. Mattiacio, Matt Brewer, and Stephen Dewhurst --  |t Bacteriophage T4 as a nanoparticle platform to display and deliver pathogen antigens : construction of an effective anthrax vaccine /  |r Pan Tao, Qin Li, Sathish B. Shivachandra, and Venigalla B. Rao. 
520 |a This volume provides readers with methods and protocols for understanding the development of recombinant viruses and their use as vaccines platforms. Recombinant Virus Vaccines: Methods and Protocols details the use of recombinant vaccines that are employed to either produce immunogens in vitro or elicit antibody production in vivo. The chapters in this book are divided into four parts: Part I explores double-stranded DNA viruses; Part II discusses negative sense single-stranded RNA viruses; Part III talks about positive sense single-stranded RNA viruses; and Part IV describes bacteriophages. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Thorough and cutting-edge, Recombinant Virus Vaccines: Methods and Protocols is a valuable resource for scientists and clinicians who are interested in learning about and adopting methods for use in basic and biomedical research directed toward generating and developing recombinant viral vaccines. 
650 0 |a Viral vaccines.  |0 http://id.loc.gov/authorities/subjects/sh85143735 
650 0 |a Synthetic vaccines.  |0 http://id.loc.gov/authorities/subjects/sh88007866 
650 1 2 |a Viral Vaccines. 
650 2 2 |a Recombination, Genetic. 
650 2 2 |a Vaccines, Synthetic. 
650 7 |a Medical  |x Immunology.  |2 bisacsh 
650 7 |a Immunology.  |2 bicssc 
650 7 |a Synthetic vaccines.  |2 fast  |0 (OCoLC)fst01141286 
650 7 |a Viral vaccines.  |2 fast  |0 (OCoLC)fst01167621 
655 2 |a Laboratory Manual. 
655 4 |a Electronic books. 
700 1 |a Ferran, Maureen C.,  |e editor.  |0 http://id.loc.gov/authorities/names/no2015083866 
700 1 |a Skuse, Gary R.,  |e editor.  |0 http://id.loc.gov/authorities/names/n94802163 
776 0 8 |i Print version:  |t Recombinant virus vaccines .  |d New York : Springer, ©2017  |z 9781493968671 
830 0 |a Methods in molecular biology (Clifton, N.J.) ;  |v v. 1581.  |x 1064-3745 
903 |a HeVa 
929 |a oclccm 
999 f f |i f0d8a141-8699-51e0-b348-d9f0ed48db1a  |s 67115a92-4d78-5ed9-ac7b-d33570aafd37 
928 |t Library of Congress classification  |a QR189.5.V5  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-1-4939-6869-5  |z Springer Nature  |g ebooks  |i 12545925